This article reviews the evidence of clinical efficacy of Traditional Chinese Medicine (TCM). Extracts from single herbs have been studied by the conventional path of drug discovery to become useful drugs in Western Medicine (WM), testifying to the pharmacological activity of herbs used in TCM formulations. Complex formulations prescribed in accordance to the principles of TCM have been in use for centuries. Much effort has been made in proving its efficacy by the criteria of Evidence Based Medicine (EBM). Problems peculiar to adopting such an approach for TCM is discussed, including issues inherent to TCM as well as the lack of well conducted randomised controlled trial to provide robust evidence. As a result the purported efficacy of TCM treatment for many conditions could not be validated by EBM criteria. A selection of studies and meta-analyses providing convincing evidence to the efficacy of some TCM treatment is cited in this review. Improved methodology and reporting in TCM clinical trials will be essential in establishing the role of TCM in the management of certain defined diseases and complementing current Western medical treatment.
INTRODUCTION
The use of Traditional Chinese Medicine (TCM) in Singapore dates back to as early as the days our forefathers settled in this island, more than a century ago. The practice of TCM has remained while our nation flourished into a developed country. In a questionnaire survey on the use of complementary and alternative medicine (CAM) in Singapore involving 468 responders in Clementi HDB estate, CAM was sought in the preceding 12 months in 76% of responders, of which TCM use constituted 88% 1 . In view of the popularity of TCM amongst the people, the Health Science Authority undertook regulation of Chinese proprietary medicine which was completed by 2001 under The Medicine Act. In parallel, implementation of registration of TCM physicians has been in full force by 2004 2 .
Attitude towards TCM varies amongst medical practitioners and layman alike, from one extreme of complete "blind faith" to the other extreme of total negation. As medical professionals practicing in a tertiary Western Medicine (WM) institute, it is to our own advantage and to the patients' benefit that we have some insight into what TCM can offer. This review aims to explore the evidence of TCM at various levels, discuss some specific issues of applying evidence based medicine (EBM) to TCM and address some problems and shortcomings of currently available evidence in this era of EBM. Selected examples of randomized controlled trials (RCT) and meta-analyses providing level 1 evidence for some TCM interventions will also be presented.
Herbs used as Drugs
Examples of drugs that were derived from medicinal herbs abound. In fact, 50% of drugs originated from natural products , where most were subsequently synthesized 3 . Table 1 shows a list of commonly used oncological drugs that were derived from herbs, providing persuasive evidence that herbs do contain pharmacologically active ingredient, Proceedings of Singapore Healthcare  Volume 20  Number 1  2011 which may explain the observed efficacy of folk medicine. One good case to illustrate the value of traditional wisdom is the story of Arsenic trioxide (ATO, 砒霜), historically used in both Western 4 and Chinese Medicine. As a component used in many TCM concoctions, ATO was identified as an active ingredient for cancer therapy by the Harbin group in 1970s 5 . Since the first report on ATO in the treatment of acute promyelocytic leukemia (APL) was published in 1992 6 , it has emerged to become the treatment of choice for relapsed APL and an alternative to chemotherapy in the upfront treatment of APL 7 . Another good example is that of Artemisinin (Qinghao 青蒿), the anti-malarial activity of which was re-discovered in the 1970s through large scale screening of traditional "heatclearing" herbs 8 . Today Artemisinin ( Artesunate) has become an indispensable medicine for the treatment of chloroquine resistant malaria or severe Falciparum malaria, backed by level 1 evidence 9,10 .
Reports on the biological activity and mechanism of action of TCM herbs by in vitro and mice experiments can be found in both Chinese and Western medical literature. The pharmacological activity of individual herb, extract or concoction can be demonstrated and often corroborate with their traditional indication based on TCM theory. Elaborated in a simplistic way by quoting examples in the field of Haematology, many TCM herbs with 'blood nourishing' (补血) action are proven to stimulate haemopoiesis [11] [12] [13] [14] . Those with "blood activating and clot dissolving" (活血化瘀) properties are shown to have anti-platelet or anticoagulant activity 15, 16 . An abundance of work is done on various TCM herbs with diverse traditional indications, especially the "Qi nourishing" (补气)herbs, demonstrating their immune potentiating as well as anti-tumour activities [17] [18] [19] . High quality basic research has elucidated the mechanism of action of several commonly used herbs, eg Scutelleria radix (Huangqin 黄芩) in inducing apoptosis in myeloma 20 and leukemia cells 21 , and Curcumin from the ginger family in chronic lymphocytic leukemia cells 22 . An excellent review 3 summarizes the mechanism of action of herb-derived small molecules in the field of anticancer therapy, which includes the inhibition of NF-кB, suppression of Activation Protein-1, cell cycle regulation, down-regulation of apoptosis suppressor proteins and modulation of tumour suppression gene P53.
The pursuit of combination therapies such as from TCM remedies has seen innovative technology applied to studying TCM remedies, where the effect of compound known to modulate immune responses and regulate cell proliferation could be analyzed 23 . Applying state-of-the-art pharmaceutical technology, even targeted drug delivery using liposomes, microspheres and nanoparticles was being explored as carriers for various extracts of TCM herbs 24 .
Applying evidence-based medicine to TCM With the above approach, the vast treasuremine of herbs has contributed greatly to drug discovery and enriched the pharmacopoeia of WM. However such approach does not do justice to TCM which is a complete and independent system from diagnostics to therapeutics based on a comprehensive set of basic TCM theory. Fig1 gives a simplified version of the basic principles of TCM approach to disease. TCM management of disease involves customized treatment to get rid of disease and restore balance within the body, which is unique to each individual. The purported efficacy of TCM that has been in use for centuries is based on such a paradigm.
To gain international acceptance, the efficacy of TCM has to be evaluated with the same standards as that for western drugs, stratified into various levels of evidence taking meta-analysis or large randomized controlled trials (RCT) with narrow confidence intervals as level 1 evidence, followed by less robust evidence as shown in the pyramid in Fig. 2 (overleaf ). In the literature there is argument both for and against applying the criteria of evidence-based medicine (EBM), which is designed for WM, to TCM 25 . The obstacles to conducting a TCM study as an RCT involves overcoming subjectivity in many aspects: from physician's interpretation of patient's subjective symptoms, physician's The individualized approach and the degree of variation involved make standardisation for an EBMtype analysis seems daunting. Format of the placebo either in acupuncture or herbal medicine trial poses further challenge to the blinding process in RCTs for TCM. The system of diagnosis and therapy according to syndrome differentiation (辨证论治) in TCM has to be modified in such a way that conclusions of the efficacy of a particular prescription can be drawn, while on the other hand it should not be altered to the extent of disregarding the basic principles of TCM and possibly compromising efficacy. In this aspect, a search of the RCTs published in the Chinese literature reveals 2 main categories in terms of the TCM arm: either following classical TCM theory of syndrome differentiation with division into a few pre-designated syndromes, each with its fixed formulation; or using a common prescription for all without any reference to TCM syndrome. There are pros and cons for both approaches. While the latter may be more standardized and therefore reproducible and more Proceedings of Singapore Healthcare  Volume 20  Number 1  2011 likely to gain widespread adoption, controversies surround the appropriateness of prescribing TCM without the guidance of TCM theory. Side effects may result and efficacy may be compromised when the TCM paradigm of syndrome differentiation is not abided by 26 . In contrast, the sub-classification of a disease into a few established TCM syndromes would avoid violating TCM theory as well as provide each syndrome with a standardised treatment, such that data can be analyzable, but at the expense of a reduced sample size and statistical power.
In addition to issues inherent to TCM that poses difficulty in pursuing an EBM approach, one other major problem impeding the effort to analyze the efficacy of TCM based on currently available data lies in the suboptimal quality of the majority of RCTs reported so far. A search on the Cochrane Collaboration website (http:// www.cochrane.org/reviews/) returned 125 reviews on "Traditional Chinese Medicine" showing that this is an area with keen interest by researchers both within and outside China. However most topics raised had failed to find convincing evidence mainly due to flaws in methodology and reporting. Some examples of topics of great impact include TCM herbs for viral upper respiratory tract infection, impaired glucose tolerance, chronic fatigue syndrome, acute pancreatitis; acupuncture for stroke rehabilitation, Bell's palsy, tinnitus and shoulder pain, to name just a few. It is a great pity as these are conditions where TCM is being employed routinely in countries where TCM is officially recognized, and believed to be beneficial or advantageous over the currently available treatment options in WM. In an analysis on the quality of reporting of RCT of TCM, the Chinese CONSORT group for TCM reported that during the period 1999-2004, 7432 RCTs were reported in 13 selected TCM journals 27 . The score based on modified CONSORT checklist comprising of 30 items was a mean of 11, and the mean Jadad score was 1.03 with only 1 study scoring 5 points, 14 with 4 points, 102 with 3 points, leaving the remaining 98.4% of reports with a score of 2 points or lower. The recognition of this shortcoming has prompted the group to propose guidelines on the optimal reporting of TCM RCT [28] [29] [30] , which is an encouraging step forward and a pre-requisite for good quality TCM RCTs in the future. 
Some TCM treatment with level 1 evidence
Despite the above problems, it is heartening to find good evidence for the efficacy of TCM treatment for a range of conditions. Acupuncture trials, probably due to its greater acceptance in western countries, are amongst those where conclusive evidence could be drawn.
In a meta-analysis by the Cochrane collaboration, acupuncture is demonstrated to be beneficial for tension type headache over sham acupuncture in terms of higher response rate and reduced number of headache days 31 . In a companion review by the same group on acupuncture as prophylaxis for migraine, acupuncture resulted in higher response rate and fewer headache episodes as compared to prophylactic drugs or routine care, and fewer adverse effects than prophylactic drug treatment 32 . Interestingly, the analysis of one subset of RCTs found no superiority for true acupuncture over sham acupuncture. This highlights the technical problem unique to acupuncture trials, where the element of placebo effect could be significant enough to overshadow any true efficacy of true acupuncture.
In a RCT studying osteoarthritis of the knee involving 294 patients, acupuncture, as compared to minimal acupuncture and waiting list group, was shown to result in a superior response rate of 52% vs 28% and 3% respectively, as well as improvement with respect to pain and joint function 33 . In an RCT on acupressure vs conventional physiotherapy for lower back pain, six sessions of treatment resulted in a significantly greater reduction in disability score in the acupressure group as compared to physiotherapy, with the benefit persisting up to 6 months 34 . Therefore acupuncture as a treatment modality for pain control has been proven to be effective for some musculo-skeletal conditions.
In comparison there is a paucity of studies with good evidence on the treatment of other medical diseases using acupuncture based on TCM theory. Notwithstanding, there is an interesting RCT in the field of Obstetrics based on TCM theory for conversion of breech presentation 35 . This involved moxibustion on an acupoint Zhiyin (at the lateral aspect of the fifth toenail) daily for 7 to 14 days compared to no treatment, in primigravidas with breech presentation at 33 weeks of gestation. This treatment resulted in increased fetal activity during the treatment period and significantly more cephalic presentation at delivery as compared to no treatment group. Another example is the use of acupuncture point stimulation for chemotherapy induced nausea and vomiting. In a meta-analysis of 11 RCTs with pharmacological treatment as comparator, acute vomiting was reduced by both manual and electroacupuncture. Acute nausea was reduced by acupressure, while non invasive electrostimulation failed to show any benefit 36 .
In contrast, clinical trials or meta-analysis on Chinese herbal medicine that qualify for level 1 evidence is scarce in the literature. Besides the lack of stringently conducted studies, the other difficulty is the great variability in the herbal combination used amongst the studies for the same condition, posing the fundamental question on the validity of pooling such studies.
The conclusion drawn from such diverse studies may then be a general one proving the efficacy of "TCM herbs" as a whole rather than anything more specific and therefore may not be of much management value. However, when done with appropriate pooling and subgroup analysis, individual RCTs of apparently diverse nature can still be analyzed as a group to yield meaningful conclusions. Astragalus membranaceus (黄芪)is a commonly used herb with a wide range of immuno-stimulatory properties demonstrated in vitro. One meta-analysis on the use of TCM for non small cell lung cancer pooled all eligible studies that compared cisplatin-containing chemotherapy with or without Astragaluscontaining TCM concoction 37 . This yielded significant superiority in the TCM + chemotherapy groups over chemotherapy-only groups, in terms of 6, 12, 24 and 36 months survival, as well as tumour response and performance status. The conclusion drawn from this meta-analysis was that Astragaluscontaining TCM may increase effectiveness of platinum-based chemotherapy when used in combination, a conclusion that lends evidence to a prevalent practice in Oncology in China and other Asian countries.
The use of TCM in combination with established conventional treatment to improve treatment efficacy, reduce toxicity and improve quality of life is a much pursued objective in oncology. One meta-analysis on nasopharyngeal carcinoma analyzed 18 RCTs of conventional therapy, of which 14 used radiotherapy, 3 used chemotherapy and 1 used a combination of both, all of which had TCM concoction in addition as the corresponding study group 38 . Survival analysis showed superiority in survival at 1 and 3 years for the study groups as compared to conventional therapy groups. Tumour response and quality of life were superior in the study groups, while oral mucositis, nausea and vomiting were reduced. Despite the diversity of herbs used for each study, it is noteworthy that 16 herbs were found to be commonly used across the studies, an important piece of information that may facilitate advancement in therapeutics. Another meta-analysis on chemotherapy without or with TCM for hepatocellular carcinoma found 24 RCTs 39 . Survival at 6, 12, 24 and 36 months as well as tumour response were all in favour of TCM in combination with chemotherapy. The authors however raised the issues of publication bias, low Jadad score and lack of standardization of the TCM formulae as limitation in drawing unequivocal conclusion from this meta-analysis data.
With regards to the importance of TCM syndrome classification in RCT, as discussed in the above section, it is interesting to look at one RCT on the treatment of irritable bowel syndrome with Chinese herbal medicine 40 . In this study with 3 treatment arms, one group had individualized TCM formulation, a second group had standardized herbal formula and the third group placebo. The efficacy of TCM was demonstrated in both the TCM groups, with significant improvement in bowel symptoms as assessed by both patient and gastroenterologist. While no difference was observed between the 2 TCM groups, the individualized TCM treatment group maintained response at 14 weeks after study completion. This may lend support to the role of TCM syndrome differentiation as an integral part of TCM practice. However the relative importance of individualizing TCM prescription over a fixed formulation may depend on the specific disease and therefore it might not be appropriate to generalise this conclusion to all conditions.
FUTURE DIRECTIONS
The above discussion illustrates the current status of TCM clinical research and studies with good evidence that meets the EBM standards. The lack of good evidence for many conditions is undoubtedly a deficiency that impedes the evaluation of TCM, but this does not imply absence of efficacy. On the contrary, lack of good evidence calls for an urgent need for studies with improved quality in methodology and reporting. A search of the website www.ClinicalTrials.gov reveals registration of over 100 clinical trials on TCM, of which some 30 are phase III or IV studies, from groups both within China and internationally. This is an encouraging sign of the attention focused on TCM and the mission many undertake to study TCM objectively and scientifically.
The conventional approach of WM drug trials starts from identification of compound and illustration of mechanism of action before moving on to Phase 1 trial, a "from bench to bedside" approach. However, TCM has been in practice for centuries. A practical approach which is more relevant for clinical research in TCM as suggested by experts is in fact starting from phase II studies to validate well-recognized TCM treatment, then working backwards to identify the active component and mechanism of action 41 . With such an approach, new and improved treatment options can be added to our armamentarium by both the discovery of small molecules for use in WM, as well as establishing a definitive role of TCM treatment, especially for some conditions where WM does not have effective therapy to offer.
In the Singapore context, the current system of practice originating from more than one century ago is one where TCM and WM run in parallel, without crossing the path of each other. With the availability of more and more convincing evidence on the role of TCM in specific conditions, TCM management for well-defined indications may eventually gain acceptance in the WM community. We may foresee a new system that integrates TCM and WM to offer the best of both worlds to our patients, who are, as we believe, at the heart of all we do.
